Venus Remedies drug 'GEMCITABINE' gets UK MHRA approval

Venus Remedies Limited, a leading research based Indian pharmaceutical company achieved yet another landmark by receiving the Market Authorisation for GEMCITABINE, one of the key products for the treatment of Cancer via de-centralised procedure from Medicine and Healthcare Regulatory Agency (MHRA) U.K.

February 02, 2011 / 18:41 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Venus Remedies Limited, a leading research based Indian pharmaceutical company achieved yet another landmark by receiving the Market Authorisation for GEMCITABINE, one of the key products for the treatment of Cancer via de-centralised procedure from Medicine and Healthcare Regulatory Agency (MHRA) U.K. The other countries in the list are Poland, Germany, Slovenia and Portugal for which the same feat has been achieved.

Mr. Pawan Chaudhary, CMD Venus Remedies said,

first published: Feb 2, 2011 06:36 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347